Evelo Biosciences to Participate in Upcoming Investor Conferences in September
Morgan Stanley 18th Annual Global Healthcare Conference. Management will host a fireside chat at
A live audio webcast of the Morgan Stanley fireside chat will be available on the Investors section of the Evelo website at http://ir.evelobio.com/news-events. A replay of the webcast will be available for approximately 30 days following the presentation.
About
Evelo currently has four product candidates in development: EDP1815, EDP1867, and EDP2939 for the treatment of inflammatory diseases including psoriasis, atopic dermatitis, and COVID-19, and EDP1503 for the treatment of cancer. Evelo is advancing additional product candidates in other disease areas.
For more information, please visit www.evelobio.com and engage with Evelo on LinkedIn.
Contact
jcotrone@evelobio.com
Source: Evelo Biosciences, Inc.